Cargando…

Prevalence of sexually transmitted infections with Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis: findings from the National Survey of Sexual Lifestyles, Attitudes and Health, Slovenia, 2016 to 2017

BACKGROUND: To inform prevention and control of sexually transmitted infections (STIs), we need reliable prevalence estimates. AIM: One objective of the Slovenian National Survey of Sexual Lifestyles, Attitudes and Health was to estimate the prevalence of STIs with Chlamydia trachomatis, Neisseria g...

Descripción completa

Detalles Bibliográficos
Autores principales: Klavs, Irena, Milavec, Maja, Berlot, Lina, Kustec, Tanja, Grgič-Vitek, Marta, Lavtar, Darja, Zaletel, Metka, Golle, Andrej, Duh, Darja, Žohar Čretnik, Tjaša
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8991734/
https://www.ncbi.nlm.nih.gov/pubmed/35393930
http://dx.doi.org/10.2807/1560-7917.ES.2022.27.14.2100284
Descripción
Sumario:BACKGROUND: To inform prevention and control of sexually transmitted infections (STIs), we need reliable prevalence estimates. AIM: One objective of the Slovenian National Survey of Sexual Lifestyles, Attitudes and Health was to estimate the prevalence of STIs with Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium and Trichomonas vaginalis. METHODS: Data were collected between October 2016 and July 2017 in a probability sample of the general population aged 18–49 years. Computer-assisted face-to-face interviewing and self-completion of questionnaires were used. Respondents were invited to provide urine samples to be tested for STIs. RESULTS: Of 1,929 survey participants, 1,087 individuals provided urine samples which were tested confidentially for C. trachomatis and a subset (n = 1,023) were tested anonymously for the other STIs. The prevalence of C. trachomatis was 0.5% (95% confidence interval (CI): 0.1–1.8) in men and 1.7% (95% CI: 0.9–3.2) in women. Age-specific prevalence was the highest among individuals aged 18–24 years, 2.8% (95% CI: 0.7–10.6) in men and 4.7% (95% CI: 1.7–12.3) in women. N. gonorrhoea was not detected. Prevalence of M. genitalium was 0.5% (95% CI: 0.1–2.2) in men and 0.3% (95% CI: 0.1–1.1) in women; the highest prevalence was among men aged 25–34 years (1.1%; 95% CI: 0.2–7.5) and women aged 35–49 years (0.5%; 95% CI: 0.1–2.0). T. vaginalis was detected in the sample from one woman (0.2%; 95% CI: 0.1–1.2). CONCLUSION: The substantial prevalence of C. trachomatis among young adults suggests gaps in testing, diagnosis and treatment.